MetaVia Inc. Files 8-K with Regulatory Updates
Ticker: MTVA · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1638287
| Field | Detail |
|---|---|
| Company | Metavia INC. (MTVA) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-update, filing
Related Tickers: MTVA
TL;DR
MetaVia Inc. (MTVA) filed an 8-K on 4/15/25 covering Reg FD, other events, and financials. Stay tuned for details.
AI Summary
MetaVia Inc. filed an 8-K on April 15, 2025, reporting on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. The company, formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This 8-K filing provides crucial updates on MetaVia Inc.'s corporate activities, including regulatory disclosures and financial information, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard corporate events and disclosures, not indicating any immediate material adverse changes.
Key Numbers
- 001-37809 — SEC File Number (Identifies the company's filing with the SEC)
- 47-2389984 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- MetaVia Inc. (company) — Registrant
- NeuroBo Pharmaceuticals, Inc. (company) — Former company name
- Gemphire Therapeutics Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Cambridge, Massachusetts (location) — Principal executive office address
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What are the 'Other Events' being reported by MetaVia Inc.?
The filing lists 'Other Events' as an item, but the specific nature of these events is not detailed in the provided text.
What is the significance of the former company names listed?
The former names, NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., indicate historical corporate changes or mergers that MetaVia Inc. has undergone.
When did MetaVia Inc. change its name from NeuroBo Pharmaceuticals, Inc.?
The date of the name change from NeuroBo Pharmaceuticals, Inc. was December 31, 2019.
What is the SIC code for MetaVia Inc.?
The Standard Industrial Classification (SIC) code for MetaVia Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding MetaVia Inc. (MTVA).